Stillidsvej 2 ApS: Financial statements 2019
CVR: 39012448
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Stillidsvej 2 ApS (CVR 39012448) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 3,596. Equity in the 2019 report amounted to DKK 37,346. The solvency ratio was 11.5%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 3,596
- Equity
- DKK 37,346
- Total Assets
- DKK 325,575
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Stillidsvej 2 ApS has published its interim report for the period October 2, 2017 – December 31, 2018.
On March 1, 2019, the company changed its name from CBD Pharma ApS to Stillidsvej 2 ApS.
About Stillidsvej 2 ApS
Stillidsvej 2 ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2017. The company is registered under the industry Detailhandel med andre fødevarer. The company was previously named CBD Pharma ApS. The management consists of Dan Ringsted Jacobsen and Lars Folkmann. The board consists of Dan Ringsted Jacobsen and Lars Folkmann. The company is owned by HPD Group ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,250 and a net result of DKK -6,350 compared with DKK -3,647 the year before. Equity in the 2025 report amounted to DKK 105,137.